Katz HR, et al: Complications of contact lens
wear after radial keratotomy in an animal model. Invest Ophthal &
Vis Sci, 22(3), 1982.
Katz HR, et al: Inhibition of contact lens induced corneal
neovascularization in radial keratotomized rabbit eyes. Invest
Ophthal & Vis Sci, 24(3), 1983.
Katz HR, et al: Intraocular lens calculation in combined penetrating
keratoplasty, cataract extraction, and intraocular lens
implantation. Invest Ophthal & Vis Sci, 25(3), 1984.
Katz HR and Elliott RD: Effect of Decadron on the inhibition of
pseudophakic endophthalmitis. Invest Ophthal & Vis Sci (Suppl),
1987; 28:175.
Levy JH and Katz HR: Effect of systemic tetracycline on Pseudomonas
aeruginosa keratitis in the rabbit. Invest Ophthal & Vis Sci (Suppl),
1988; 29: 1103.
Wahl JC, Katz HR: Infectious keratitis in Baltimore. Invest Ophthal
and Vis Sci (Suppl), 1989; 30:37.
Sarfarazi FA, Katz HR: Topical ciprofloxacin treatment of gentamicin-sensitive
and gentamicin-resistant pseudomonas keratitis. Invest Ophthal and
Vis Sci (Suppl), 1989; 30:39.
Sarfarazi FA, Parks DJ, Katz HR: Topical ciprofloxacin treatment of
methicillin-resistant Staphylococcus aureus keratitis in a rabbit
model. Invest Ophthal and Vis Sci (Suppl), 1990; 31:484.
Katz HR, Cytryn AS, Parks DJ: Treatment of P. aeruginosa
endophthalmitis in a rabbit model with intravitreal ciprofloxacin.
Invest Ophthal and Vis Sci (Suppl), 1991; 32:706.
Parks DJ, Cytryn AS, Sarfarazi FA, Katz HR: Subconjunctival
ciprofloxacin inhibits pseudophakic endophthalmitis in a rabbit
model. Invest Ophthal and Vis Sci (Suppl), 1991; 32:706.
Abrams DA, Sarfarazi FA, Parks DJ, Katz HR: Topical ciprofloxacin
versus conventional antibiotic therapy in the treatment of
ulcerative keratitis. Invest Ophthal and Vis Sci (Suppl), 1991;
32:1171.
Kaplan HJ, Cytryn AS, Parks DJ, Katz HR: Vitreous levels of
ciprofloxacin after intravitreal injection in the rabbit. Invest
Ophthal and Vis Sci (Suppl), 1992; 33:729.
Parks DJ, Snyder ME, Cytryn AS, Katz HR: Retinal toxicity of
intravitreal ciprofloxacin in a rabbit model. Invest Ophthal and Vis
Sci (Suppl), 1992; 33:747.
Cytryn AS, Kaufman G, Parks DJ, Goldman EJ, Katz HR: The role of
early vitrectomy and intravitreal ciprofloxacin in the management of
Staphylococcus aureus endophthalmitis in the rabbit. Invest Ophthal
and Vis Sci (Suppl), 1992; 33:747.
Katz HR, Cytryn AS, Parks DJ: Aqueous and vitreous levels of
ciprofloxacin after subconjunctival injection in the rabbit. Invest
Ophthal and Vis Sci (Suppl), 1992; 33:1014.
Altman ME, Snyder ME, Katz HR: Bacterial superinfection of dendritic
keratitis. Invest Ophthal and Vis Sci (Suppl), 1993; 34:855.
Snyder ME, Kaplan HJ, Katz HR, Green WR: YAG Laser anterior stromal
puncture of the cornea: Histology and clinical outcomes. Invest
Ophthal and Vis Sci (Suppl), 1993; 34:1247.
Liss RA, Kaplan HJ, Awh CC, Snyder ME, Katz HR: Treatment of
experimental Staphylococcus epidermidis endophthalmitis with
intravitreal ciprofloxacin. Invest Ophthal and Vis Sci (Suppl),
1993; 34:1260.
Levey SB, Hirschbein M, Abrams DA, Katz HR: A multivariate analysis
of the outcome and management of ulcerative keratitis. Invest
Ophthal and Vis Sci (Suppl), 1994; 35:1676.
Schwartz GF, Katz HR, Abrams DA, Levey SB, Pollack IP, Kosoko O:
Changes in corneal topography, ultrasonic pachymetry and specular
microscopy following trabeculectomy. Invest Ophthal and Vis Sci (Suppl),
1995; 36:S343.
Bañez MT, Levey SB, Katz HR, Abrams DA: An analysis of factors
affecting enhancement rate in patients undergoing radial keratotomy.
Invest Ophthal and Vis Sci (Suppl), 1995; 36:S434.
Levey SB, Katz HR, Abrams DA: Change in pachymetry of eyes
undergoing radial keratotomy. Invest Ophthal and Vis Sci (Suppl),
1995; 36:S435.
Levine ES, Levey SB, Katz HR, Abrams DA: Efficacy of topical
ciprofloxacin 0.3% in the treatment of ulcerative keratitis in
humans. Invest Ophthal and Vis Sci (Suppl), 1995; 36:S1004.
Levey SB, Katz HR, Abrams DA, Marsh M: The role of cultures in the
management of ulcerative keratitis. Accepted as paper presentation
AAO 1995 Annual Meeting, Atlanta, Georgia.
Epley KD, Katz HR, Herling I, Lasky JB: Platinum spatula versus
mini-tip culturette in culturing bacterial keratitis in rabbits.
Invest Ophthal and Vis Sci (Suppl), 1996; 37:S874.
Abrams DA, Lasky JB, Katz HR, Green WR: A case report of
histopathology and family pedigree in a patient with lecithin
cholesterol acyltransferase deficiency. Invest Ophthal and Vis Sci (Suppl),
1996; 37:S1017.
Lasky JB, Katz HR, Abrams DA, Epley KD: Stability of refraction
after bidirectional radial keratotomy. Invest Ophthal and Vis Sci (Suppl),
1996; 37:S322.
Katz HR, Wapner FJ, Laibovitz RA, et al: Comparison of ciprofloxacin
ophthalmic ointment 0.3% vs. ciprofloxacin ophthalmic solution 0.3%
(Ciloxan) monotherapy in the treatment of acute bacterial
conjunctivitis. Invest Ophthal and Vis Sci (Suppl), 1996; 37:S1033.
Hyndiuk RA, Eiferman RA, Caldwell DR, Rosenwasser GO, Santos CI,
Katz HR, et al: Comparative minimal inhibitory concentrations of
ciprofloxacin, tobramycin and cefazolin against corneal ulcer
isolates. Invest Ophthal and Vis Sci (Suppl), 1996; 37:S875.
Katz HR, LaBorwit SE, Hirschbein MJ: A retrospective study of
seasonal influence on ulcerative keratitis. Invest Ophthal and Vis
Sci (Suppl), 1997; 38:S136.
Marx JL, Epley KD, Katz HR, Levine ES: A simplified technique for
stable transscleral suture fixation of posterior chamber intraocular
lenses. Invest Ophthal and Vis Sci (Suppl), 1997; 38:S174.
Lasky JB, Katz HR: Nd:YAG laser treatment of recurrent erosion.
Invest Ophthal and Vis Sci (Suppl), 1997; 38:S424.
Epley KD, Katz HR: Platinum spatula versus mini-tip culturette in
culturing presumed bacterial keratitis in humans. Invest Ophthal and
Vis Sci (Suppl), 1997; 38:S869.
Snyder-Perlmutter LS, Katz HR, Oswald MR, LaBorwit SE: The learning
curve for conversion from scleral tunnel to clear cornea
phacoemulsification. Invest Ophthal and Vis Sci (Suppl), 1998.
Katz HR, Oswald MR, Snyder MR: Comparison of peribulbar versus
topical anesthesia in clear cornea phacoemulsification. Invest
Ophthal and Vis Sci (Suppl), 1998.
LaBorwit, Katz KR, Hirschbein MJ, Oswald MR, Snyder LS, Schwartz KS,
Herling IP: Topical ciprofloxacin compared to topical ofloxacin in
the early treatment of Pseudomonas keratitis in a rabbit model.
Invest Ophthal and Vis Sci (Suppl), 1998.
Katz HR, Snyder-Perlmutter LS: The Use of Topical Fluoroquinolones
to Reduce Conjunctival Flora in Human Subjects for Surgical
Prophylaxis. J Cataract Refract Surg (Suppl), 1999.
Snyder-Perlmutter LS, Katz HR, Oswald MR: The effectiveness of
topical ciprofloxacin 0.3% on the reduction of human conjunctival
bacterial flora over time. Invest Ophthal and Vis Sci (Suppl), 1999.
Oswald MR, Katz HR, Snyder-Perlmutter LS: Factors affecting graft
rejection. Invest Ophthal and Vis Sci (Suppl), 1999.
Stroman DW, Cupp, GA, Katz, HR, Do, D: Characterization and
Antibiotic Susceptibility of Bacteria from Healthy Eyes in the US
and India. ARVO-2002
Nduaguba C, Katz, HR: Early Visual Recovery in Keratoconus Patients
Undergoing Penetrating Keratoplasty With a Single Running Suture vs.
a Combined Running and Interrupted Suture Technique. ARVO-2002
Adler, R, Katz HR: The Use of Single-Piece Acrylic Intra-Ocular
Lenses to Reduce Post-Operative Complications. ARVO-2002
Katz, HR et al: “Moxifloxacin Ophthalmic Solution 0.5% Hastens Cure
and Eradicates the Causative Pathogens of Bacterial Conjunctivitis
in Pediatric and Adult Patients”
ARVO 2003
Katz, HR et al: “Human Aqueous Humor Concentration of Moxifloxacin
Following To Multiple-Dose Topical Ocular Dosing Regimens of Vigamox”
ARVO 2004
Published Abstracts
